Fuller & Thaler (NASDAQ: COLL) reports 5.03% beneficial stake in common stock

Rhea-AI Filing Summary

Fuller & Thaler Asset Management, Inc., a California corporation, reports beneficial ownership of 1,632,780.71 shares of PHARMACEUTICAL, INC common stock (CUSIP 19459J104), representing 5.03% of the class as of June 30, 2026.

Fuller & Thaler has sole voting and sole dispositive power over these shares and no shared voting or dispositive power. The position is held in accounts for advisory clients, each of whom has the right to receive dividends and sale proceeds on the shares.

Key Figures

Beneficial ownership: 1,632,780.71 shares Percent of class: 5.03% Sole voting power: 1,632,780.71 shares +1 more

4 metrics

Beneficial ownership 1,632,780.71 shares Common stock beneficially owned by Fuller & Thaler Asset Management, Inc.

Percent of class 5.03% Portion of PHARMACEUTICAL, INC common stock class held beneficially

Sole voting power 1,632,780.71 shares Shares over which Fuller & Thaler can vote or direct the vote

Sole dispositive power 1,632,780.71 shares Shares over which Fuller & Thaler can dispose or direct disposition

Key Terms

beneficial owner, sole voting power, sole dispositive power, Investment Company Act of 1940

4 terms

beneficial owner financial

"Fuller & Thaler Asset Management, Inc. is deemed to be thebeneficial owner of the number of securities"

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

sole voting power financial

"Sole Voting Power 1,632,780.71"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

sole dispositive power financial

"Sole Dispositive Power 1,632,780.71"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

Investment Company Act of 1940 regulatory

"A listing of the shareholders of an investment company registered under the Investment Company Act of 1940"

A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.

FAQ

What percentage of COLL does Fuller & Thaler Asset Management own?

Fuller & Thaler Asset Management reports beneficial ownership of 5.03% of COLL common stock, equal to 1,632,780.71 shares, with sole voting and dispositive power over this position.

How many COLL shares are beneficially owned by Fuller & Thaler Asset Management?

Fuller & Thaler Asset Management is the beneficial owner of 1,632,780.71 COLL common shares, representing 5.03% of the class, with no shared voting or dispositive power reported.

Does Fuller & Thaler control voting for its COLL shares?

Yes. Fuller & Thaler Asset Management reports sole power to vote or direct the vote over 1,632,780.71 COLL shares and no shared voting power, indicating it controls how these shares are voted.

Who receives dividends and sale proceeds from Fuller & Thaler’s COLL holdings?

The COLL shares are held for Fuller & Thaler’s advisory clients, each of whom has the right to receive dividends and proceeds from any sale of the common stock in their accounts.

Is Fuller & Thaler’s COLL ownership direct or on behalf of clients?

Fuller & Thaler is deemed the beneficial owner due to its role as investment adviser, while its clients hold the economic interest, including rights to dividends and sale proceeds.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 05:26 PM Accepted by SEC EDGAR 08/14/2026 - 05:25 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

COLLEGIUM PHARMACEUTICAL, INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

19459J104

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 19459J104

1

Names of Reporting Persons

Fuller & Thaler Asset Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,632,780.71
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,632,780.71
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,632,780.71

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.03 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: COLLEGIUM PHARMACEUTICAL, INC
(b)	Address of issuer's principal executive offices: 100 Technology Center Drive, Stoughton, MA 02072
Item 2.
(a)	Name of person filing: Fuller & Thaler Asset Management, Inc.
(b)	Address or principal business office or, if none, residence: 411 Borel Avenue, Suite 300, San Mateo, CA 94402
(c)	Citizenship: California corporation
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 19459J104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,632,780.71
(b)	Percent of class: 5.03 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,632,780.71
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 1,632,780.71
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Fuller & Thaler Asset Management, Inc. is deemed to be thebeneficial owner of the number of securities reflected in Items 5-9 and 11 of page two (2) of this Schedule 13G pursuant toseparate arrangements whereby it acts as investment adviser tocertain persons. Each person for whom Fuller & Thaler AssetManagement, Inc. acts as investment adviser has the right toreceive or the power to direct the receipt of dividends from,or the proceeds from the sale of, the Common Stock.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Fuller & Thaler Asset Management, Inc.

Signature:	/s/ Hanna Zanoni
Name/Title:	Chief Compliance Officer
Date:	08/14/2026